Le Tohic S, Basso S, Peillard L
Département Pharmacie Biologie, Agence régionale de santé Provence-Alpes-Côte d'Azur, 132, boulevard de Paris, 13002 Marseille, France; Service de pharmacie hospitalière, Hôpital d'Instruction des Armées Laveran, 34, boulevard Laveran, 13013 Marseille, France.
Département Pharmacie Biologie, Agence régionale de santé Provence-Alpes-Côte d'Azur, 132, boulevard de Paris, 13002 Marseille, France.
Ann Pharm Fr. 2022 Sep;80(5):697-710. doi: 10.1016/j.pharma.2022.01.006. Epub 2022 Jan 24.
COVID-19 caused more than 260,000 hospitalizations and nearly 64,000 deaths in France in 2020. Vaccination has become the best hope for gaining control of the pandemic. Our objective is to map the major risks associated with organization of the start of a COVID-19 immunization campaign in the Provence-Alpes-Côte d'Azur region, from December 2020 to April 2021 (inclusive).
The process associated with organization of a COVID-19 immunization campaign was described. Risks, causes, consequences and control elements were identified by 14 semi-structured interviews, involving 19 professionals involved in the important stages in the process. The analysis was performed using the process approach and by a Failure Mode, Effects and Criticality Analysis (FMECA).
The process is divided into two approaches, one collective and one individual. Forty-seven risks have been identified and 15 actions proposed. Regional supply logistics chain, vaccination sites, appointment management and the Vaccine-COVID information system are the critical points. Overwork is the most common risk, which has been experienced by the study participants (n=18). It favours the disaffection of the health professionals, which is the major threat of this organization. Eligibility, medical consultation, and the post-vaccination period are under control.
Principal risks associated with organization of a COVID-19 immunization campaign have been identified and action plans have been proposed to optimize current and future practices. It gives a regional vision, to be compared with other regional, national, and international data.
2020年,新型冠状病毒肺炎(COVID-19)在法国导致超过26万例住院病例和近6.4万例死亡。疫苗接种已成为控制疫情的最大希望。我们的目标是梳理出2020年12月至2021年4月(含)期间,在普罗旺斯-阿尔卑斯-蓝色海岸大区开展COVID-19免疫接种运动初期组织工作所涉及的主要风险。
描述了与COVID-19免疫接种运动组织工作相关的流程。通过14次半结构化访谈确定了风险、原因、后果及控制因素,访谈对象为参与该流程重要阶段的19名专业人员。分析采用流程方法及失效模式、影响及危害性分析(FMECA)。
该流程分为集体和个体两种方式。已识别出47项风险并提出15项措施。区域供应物流链、接种点、预约管理及疫苗-COVID信息系统为关键点。工作过度是最常见的风险,参与研究的人员(n = 18)均有体会。这会导致卫生专业人员工作热情降低,而这是该组织面临的主要威胁。资格审查、医学咨询及接种后阶段处于可控状态。
已识别出与COVID-19免疫接种运动组织工作相关的主要风险,并提出了行动计划以优化当前及未来的做法。本研究给出了一个区域视角,可与其他区域、国家及国际数据进行比较。